KLAC trades against a final fair-value range of $735.74-$1,243.87, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $736, high $1244, with mid-point at $984.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$984
Margin of safety
-89.9%
Confidence
84/100
Moat
9/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$1,869.19Price
Low $735.74
Mid $984.41
High $1,243.87
KLAC trades against a final fair-value range of $735.74-$1,243.87, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Dominant market share in advanced
Dominant market share in advanced metrology and inspection.
High capital intensity of advanced
High capital intensity of advanced node defect detection.
Bull thesis
Value: Extreme overvaluation relative to normalized cash flows.
Reverse DCF for KLAC (KLAC) backs out the revenue or earnings growth rate the current share price implies, holding terminal value, margin, and discount-rate assumptions constant.
We compare the implied rate to our own forecast deceleration curve and to the historical five-year actual. When the implied rate exceeds the realistic ceiling, the price is pricing in optimism the business has not yet demonstrated.
Reverse DCF uses cost of equity (Ke), not WACC, to stay consistent with the EPS-based forward valuation models. Ke is derived from CAPM with adjusted beta; the strict and moderate variants are documented in the assumption ledger.
When the implied growth rate is below our forecast, the market is underpricing the business; when it is above, the market is overpricing. The reverse-DCF read is one of four lenses that feed the composite fair-value range and the rating band.
FAQ
KLAC — frequently asked questions
Based on our latest analysis, KLAC looks meaningfully overvalued. The current price is $1869 versus a composite fair-value midpoint of $984 (range $736–$1244), which implies roughly 47.3% downside to the midpoint.
Our composite fair-value range for KLAC is $736–$1244, with a midpoint of $984. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for KLAC's archetype.
Our current rating for KLAC is Sell with a confidence score of 84/100. KLAC is rated Sell at $1,869.19 versus the reconciled fair value midpoint of $984.41, implying -47.33% upside/downside. Confidence is separately disclosed at 84/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for KLAC are: China Export Ban Expansion; WFE Cyclical Collapse; Margin Compression via R&D. The single biggest risk is Risk: High exposure to geopolitical export restrictions and industry down-cycles.
Our current rating for KLAC is Sell, issued with a confidence score of 84/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($736–$1244) versus the current price of $1869.
KLAC is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for KLAC.